The Prognostic Significance of CXCL16 and Its Receptor C-X-C Chemokine Receptor 6 in Prostate Cancer

American Journal of Pathology

Volumn 185, Issue 10, 2015, Pages 2722-2730

  Richardsen, Elin ^a,b   Ness, Nora ^a   Melbø Jørgensen, Christian ^a,c   Johannesen, Charles ^a   Grindstad, Thea ^a   Nordbakken, Cecilie ^b   Al Saad, Samer ^a,b   Andersen, Sigve ^a,b   Dønnem, Tom ^a,b   Nordby, Yngve ^a,b   Bremnes, Roy M ^a,b   Busund, Lill Tove ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; CXCL16 PROTEIN, HUMAN; CXCR6 PROTEIN, HUMAN; SCAVENGER RECEPTOR; VIRUS RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; EPITHELIUM TUMOR; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; TISSUE MICROARRAY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PROSTATE TUMOR; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINES, CXC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; RECEPTORS, CHEMOKINE; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS;

EID: 84943642909     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.06.013     Document Type: Article

References (34)

1. P. Allavena, G. Germano, F. Marchesi, and A. Mantovani Chemokines in cancer related inflammation Exp Cell Res 317 2011 664 673
2. A. Mantovani, B. Savino, M. Locati, L. Zammataro, P. Allavena, and R. Bonecchi The chemokine system in cancer biology and therapy Cytokine Growth Factor Rev 21 2010 27 39
3. C.H. Kim, E.J. Kunkel, J. Boisvert, B. Johnston, J.J. Campbell, M.C. Genovese, H.B. Greenberg, and E.C. Butcher Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential J Clin Invest 107 2001 595 601
4. D. Unutmaz, W. Xiang, M.J. Sunshine, J. Campbell, E. Butcher, and D.R. Littman The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse J Immunol 165 2000 3284 3292
5. T. Nakayama, K. Hieshima, D. Izawa, Y. Tatsumi, A. Kanamaru, and O. Yoshie Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues J Immunol 170 2003 1136 1140
6. M. Heydtmann, and D.H. Adams Chemokines in the immunopathogenesis of hepatitis C infection Hepatology 49 2009 676 688
7. T. Sato, H. Thorlacius, B. Johnston, T.L. Staton, W. Xiang, D.R. Littman, and E.C. Butcher Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver J Immunol 174 2005 277 283
8. M. Matloubian, A. David, S. Engel, J.E. Ryan, and J.G. Cyster A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo Nat Immunol 1 2000 298 304
9. T. Shimaoka, N. Kume, M. Minami, K. Hayashida, H. Kataoka, T. Kita, and S. Yonehara Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages J Biol Chem 275 2000 40663 40666
10. A. Wilbanks, S.C. Zondlo, K. Murphy, S. Mak, D. Soler, P. Langdon, D.P. Andrew, L. Wu, and M. Briskin Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines J Immunol 66 2001 5145 5154
11. M. Tohyama, K. Sayama, H. Komatsuzawa, Y. Hanakawa, Y. Shirakata, X. Dai, L. Yang, S. Tokumaru, H. Nagai, S. Hirakawa, M. Sugai, and K. Hashimoto CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes Int Immunol 19 2007 1095 1102
12. L. Deng, N. Chen, Y. Li, H. Zheng, and Q. Lei CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer Biochem Biophys Acta 1806 2010 42 49
13. K. Hattermann, A. Ludwig, V. Gieselmann, J. Held-Feindt, and R. Mentlein The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6 Mol Cell Neurosci 39 2008 133 141
14. L. Zhang, L. Ran, G.E. Garcia, X.H. Wang, S. Han, J. Du, and W.E. Mitch Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration Am J Pathol 175 2009 2518 2527
15. A.W.T. van Lieshout, C. Popa, F. Meyer-Wentrup, H.L. Lemmers, A.F. Stalenhoef, G.J. Adema, P.L. van Riel, L.J. van Tits, and T.R. Radstake Circulating CXCL16 is not related to circulating oxLDL in patients with rheumatoid arthritis Biochem Biophys Res Commun 355 2007 392 397
16. J. Diegelmann, J. Seiderer, J.H. Niess, D. Haller, B. Göke, H.C. Reinecker, and S. Brand Expression and regulation of the chemokine CXCL16 in Crohns disease and models of intestinal inflammation Inflamm Bowel Dis 16 2010 1871 1881
17. M. Darash-Yahana, J.W. Gillespie, S.M. Hewitt, Y.Y.K. Chen, S. Maeda, I. Stein, S.P. Singh, R.B. Bedolla, A. Peled, D.A. Troyer, E. Pikarsky, M. Karin, and J.M. Farber The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers PLoS One 4 2009 e6695
18. W. Hu, Y. Liu, W. Zhou, L. Si, and L. Ren CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro PLoS One 9 2014 e99056
19. J. Meijer, J. Ogink, B. Kreike, D. Nuyten, K.E. De Visser, and E. Roos The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation Cancer Res 68 2008 4701 4708
20. A.M. De Marzo, V.L. Marchi, J.I. Epstein, and W.G. Nelson Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis Am J Pathol 155 1999 1985 1992
21. A.M. De Marzo, E.A. Platz, S. Sutcliffe, J. Xu, H. Grönberg, C.G. Drake, Y. Nakai, W.B. Isaacs, and W.G. Nelson Inflammation in prostate carcinogenesis Nat Rev Cancer 7 2007 256 269
22. W. Zhou, W. Hu, Z. Wu, X. Zheng, and B. Wang Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer Zhonghua Yi Xue Za Zhi 90 2010 947 951
23. W. Hu, X. Zhen, B. Xiong, B. Wang, W. Zhang, and W. Zhou CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells Cancer Sci 99 2008 1362 1369
24. H.K. Ha, W. Lee, H.J. Park, S.D. Lee, J.Z. Lee, and M.K. Chung Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer Mol Med Rep 4 2011 419 424
25. Y. Lu, J. Wang, Y. Xu, A.E. Koch, Z. Cai, X. Chen, D.L. Galson, R.S. Taichman, and J. Zhang CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro Mol Cancer Res 6 2008 546 554
26. J.I. Epstein An update of the Gleason grading system J Urol 183 2010 433 440
27. B. Helpap, and L. Egevad Modified Gleason grading: an updated review Histol Histopathol 24 2009 661 666
28. S. Andersen, E. Richardsen, Y. Nordby, N. Ness, O. Størkersen, K. Al-Shibli, T. Donnem, H. Bertilsson, L.T. Busund, A. Angelsen, and R.M. Bremnes Disease-specific outcomes of radical prostatectomies in Northern Norway: a case for the impact of perineural infiltration and postoperative PSA-doubling time BMC Urol 14 2014 49
29. R.M. Bremnes, R. Veve, E. Gabrielson, F.R. Hirsch, A. Baron, L. Bemis, R.M. Gemmill, H.A. Drabkin, and W.A. Franklin High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer J Clin Oncol 15 2002 2417 2428
30. N. Ness, S. Andersen, A. Valkov, Y. Nordby, T. Donnem, S. Al-Saad, L.T. Busund, R.M. Bremnes, and E. Richardsen Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer Prostate 74 2014 1452 1461
31. D. Raman, P.J. Baugher, Y.M. Thu, and A. Richmond Role of chemokines in tumor growth Cancer Lett 28 2007 137 165
32. A.M. De Marzo, Y. Nakai, and W.G. Nelson Inflammation, atrophy, and prostate carcinogenesis Urol Oncol 25 2007 398 400
33. G.S. Palapattu, S. Sutcliffe, P.J. Bastian, E.A. Platz, A.M. De Marzo, W.B. Isaacs, and W.G. Nelson Prostate carcinogenesis and inflammation emerging insights Carcinogenesis 26 2005 1170 1181
34. S. Hojo, K. Koizumi, K. Tsuneyama, Y. Arita, Z. Cui, K. Shinohara, T. Minami, I. Hashimoto, T. Nakayama, H. Sakurai, Y. Takano, O. Yoshie, K. Tsukada, and I. Saiki High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer Cancer Res 67 2007 4725 4731